HIV is associated with thrombophilia and high D-dimer in children and adolescents

Giuseppe Pontrelli1, Alessandra M Martino, Hyppolite K Tchidjou

  • 1Department of Public Health,Ospedale Pediatrico Bambino Gesù, Rome, Italy. giuseppe.pontrelli@opbg.net

AIDS (London, England)
|February 20, 2010
PubMed

Insights

High viral replication in HIV-infected youth is linked to blood clotting problems. This suggests that controlling HIV viral load may improve coagulation and reduce cardiovascular risk in children.

Area of Science:

  • Pediatric Infectious Diseases
  • Hematology
  • Cardiovascular Health

Background:

  • Combination antiretroviral therapy (cART) has improved survival for HIV-infected individuals, shifting focus to non-AIDS comorbidities like cardiovascular disease.
  • Thrombosis and atherosclerosis are increasingly recognized as significant risks in HIV-infected patients, particularly with improved longevity.

Purpose of the Study:

  • To investigate the association between viral replication levels and coagulation abnormalities in children and adolescents with HIV.
  • To assess the prevalence of thrombophilic markers in this pediatric cohort.

Main Methods:

  • A cross-sectional study was conducted on HIV-infected children and adolescents.
  • Assayed protein S, protein C, antithrombin activity, fibrinogen, D-dimer, hs-CRP, and homocysteine.
  • Compared results between patients with high viral load (HVL) and low viral load (LVL), adjusting for covariates.

Main Results:

  • 51% had protein S deficiency and 8% had protein C deficiency.
  • The HVL group showed significantly reduced protein S, protein C, and antithrombin activities compared to the LVL group.
  • High viral load was independently associated with decreased protein S activity and increased D-dimer levels.

Conclusions:

  • HIV-infected children and adolescents exhibit a high prevalence of thrombophilic abnormalities.
  • High viral replication is an independent risk factor for decreased protein S and increased D-dimer.
  • Suppressive HIV therapy may benefit coagulation homeostasis, highlighting the need for early cardiovascular risk factor management.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.